Balaxi expecting a rounding bottomBalaxi , made a base
398 is the stop loss on day close basis
Expecting 500 levels by end of Jan'24
459.63 MINR
3.39 BINR
1.92 M
About BALAXI PHARMACEUTI
Sector
Industry
CEO
Ashish Maheshwari
Website
Headquarters
Hyderabad
Employees (FY)
51
Founded
1942
ISIN
INE618N01014
FIGI
BBG00BKS8ST0
Balaxi Pharmaceuticals Ltd. is an intellectual property rights-based pharmaceutical company. It engages in the business of international wholesale trading of pharmaceuticals, builders' hardware, and fast-moving consumer goods products. The company was founded by Ashish Maheshwari and Minoshi Maheshwari on September 28, 1942 and is headquartered in Hyderabad, India.
BalaxiOne more Pharma stock that looks for a flag breakout and RSI has already given a breakout and almost nearing 52 week breakout.
More volumes are being seen for the last couple of weeks.
Safe entry only after flag breakout
Flag & Pole BreakoutStock has broken flag and pole pattern and has taken support above it. Buy at 611, accumulate till 448. Stop loss 445 for a target of 1510.
BUY CALL HELLO TRADER,
I WOULD LIKE TO RECOMMEND TO BUY NSE:BALAXI AT CMP
TARGET PRICE - 1090
EXPECTED PROFIT - 80%
I'M RECOMMENDING THIS STOCK AS PER TA
THANKYOU
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BALAXI is 579.80 INR — it has increased by 0.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange BALAXI PHARMACEUTI stocks are traded under the ticker BALAXI.
BALAXI stock is 5.91% volatile and has beta coefficient of 0.29. Check out the list of the most volatile stocks — is BALAXI PHARMACEUTI there?
Yes, you can track BALAXI PHARMACEUTI financials in yearly and quarterly reports right on TradingView.
BALAXI stock has risen by 1.86% compared to the previous week, the month change is a 20.04% rise, over the last year BALAXI PHARMACEUTI has showed a 3.59% increase.
BALAXI net income for the last quarter is 135.94 M INR, while the quarter before that showed −413.43 M INR of net income which accounts for 132.88% change. Track more BALAXI PHARMACEUTI financial stats to get the full picture.
Today BALAXI PHARMACEUTI has the market capitalization of 6.22 B, it has increased by 3.04% over the last week.
BALAXI PHARMACEUTI dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 0.14% and 1.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, BALAXI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BALAXI PHARMACEUTI stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 51.00 employees. See our rating of the largest employees — is BALAXI PHARMACEUTI on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BALAXI PHARMACEUTI technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BALAXI PHARMACEUTI stock shows the strong buy signal. See more of BALAXI PHARMACEUTI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.